GoHealth, Inc. Receives Nasdaq Delisting Notice Over Market Value Requirement

• Date of Event: March 18, 2026
• Company: GoHealth, Inc. (Nasdaq: GOCO)
• Location: Chicago, IL
• Filing Type: Current Report on Form 8-K

Key Developments

GoHealth, Inc., a leading insurance agent, broker, and service provider, has received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC. The notice, dated March 18, 2026, informs the company that it is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires listed companies on The Nasdaq Global Market to maintain a minimum market value of listed securities of \$35 million.

Details of Non-Compliance

• Nasdaq Rule 5550(b)(2): GoHealth failed to maintain a minimum market value of listed securities (MVLS) of \$35 million.
• Alternative Standards: The notice further indicates that GoHealth does not meet alternative listing standards, meaning it does not qualify for continued listing through other criteria.
• Compliance Period: GoHealth has a 180-calendar day period (the “Compliance Period”) to regain compliance. To do so, its market value of listed securities must close at \$35 million or more for at least 10 consecutive business days (Nasdaq may require up to 20 days at its discretion).
• Delisting Risk: If GoHealth fails to meet the MVLS requirement within the Compliance Period, Nasdaq will issue a formal delisting notice. At that point, GoHealth may appeal the determination to a Nasdaq Hearings Panel, which would temporarily stay any suspension or delisting while the appeal is heard.
• Current Actions: The company is currently evaluating options to regain compliance with the MVLS requirement. However, there is no guarantee that GoHealth will be able to regain compliance or maintain its Nasdaq listing.

Potential Impact for Shareholders

• Price Sensitivity: A potential delisting from Nasdaq is a material event that could significantly impact GoHealth’s share price, liquidity, and ability to access capital markets.
• Uncertainty: The company’s inability to meet listing standards raises concerns about its financial health and market confidence.
• Forward-Looking Statements: GoHealth cautions that its plans and ability to regain compliance are subject to risks and uncertainties. Further details on risks can be found in its previous SEC filings, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Other Notable Information

• Trading Symbol: GOCO
• Class A Common Stock: \$0.0001 par value per share
• Exchange: The Nasdaq Global Market
• Company Contact: Chief Legal Officer, Bradley M. Burd

Summary

GoHealth, Inc. faces a significant challenge after receiving a Nasdaq notice regarding non-compliance with minimum market value requirements. This development puts its Nasdaq listing at risk and may have direct consequences for investors, including potential volatility in share price and reduced liquidity. Shareholders should monitor further updates closely, as the outcome of the Compliance Period and any potential appeal could materially affect their investment.

Disclaimer: This article summarizes information from GoHealth, Inc.’s SEC Form 8-K filing and is intended for informational purposes only. It does not constitute investment advice. Investors should consult official filings and professional advisors before making any investment decisions. The company’s ability to regain compliance is uncertain and subject to risks described in its official reports.

View GoHealth, Inc. Historical chart here